Objective: Epilepsy surgery is underutilized globally due to patient and/or caregiver reluctance and neurologist knowledge gaps. In Pakistan, the treatment gap is 70%-94% for medically refractory epilepsy (MRE). This study assessed the knowledge and practices of neurologists and patients to identify barriers to adequate epilepsy surgery provision in Pakistan.
Methods: The authors conducted a cross-sectional study consisting of two surveys. One survey was designed for epilepsy patients and their caregivers. The medical records of patients diagnosed with epilepsy at the authors' hospital between July 2018 and December 2020 were retrieved from the neurophysiology database. Patients or their caregivers were then contacted via telephone to complete the survey. The second survey was designed for neurologists working in Pakistan. This form was sent via email.
Results: For the patient survey, 250 patients or caregivers were contacted, of whom 194 responded. The median age of the patients was 10 years (IQR 6-14 years). The authors found that 74.2% (n = 144) of the patients were unaware of surgical options in MRE. Forty-eight (24.7%) patients/caregivers reported more than 1 seizure per month, and 29 (60.4%) of them were unaware of the surgical treatment. Seizures were disabling in 56.7% (n = 110) of the patients. Patients taking more antiepileptic drugs were significantly more likely to be aware of surgical options (p = 0.001). For the neurologist survey, only 6.6% (4/61) always discussed epilepsy surgery with MRE patients. Around half of the neurologists (n = 27, 44.3%) had never referred a patient for epilepsy surgery. However, 95.1% (n = 58) were aware of the underutilization of epilepsy surgery, and 67.2% (n = 41) believed that epilepsy surgery is underrecommended. Almost all neurologists (n = 60, 98.4%) believed that comprehensive epilepsy treatment centers are required in the country.
Conclusions: These surveys demonstrated a major barrier in patient and neurologist awareness, in contrast to high-income countries where physician awareness is adequate but patient perceptions and stigmas are the main barriers. Addressing these barriers requires multifaceted, locally tailored approaches.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3171/2024.12.FOCUS24644 | DOI Listing |
Epilepsia
March 2025
Neuroscience and Medical Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy.
Objective: This study was undertaken to prospectively assess the frequency and type of psychiatric disorders (PDs) in pediatric surgical candidates and evaluate the effects of epilepsy surgery on their psychopathological profile.
Methods: This is a prospective controlled study. Psychopathology was assessed using both diagnostic interviews and questionnaires completed by clinicians, parents, and whenever possible, patients, at baseline (T0) and 1 year after surgery in operated patients (T1) and 1 year after the first evaluation in a control group of nonoperated patients (T1).
CNS Neurosci Ther
March 2025
Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.
Aims: This study aims to evaluate the role of stereo-electroencephalography (SEEG) in managing pediatric patients with drug-resistant epilepsy. We further explore prognostic factors influencing surgical outcomes following SEEG-guided resective or disconnective surgery.
Methods: A retrospective review was conducted on pediatric patients who underwent SEEG at the Pediatric Epilepsy Center, Peking University First Hospital, between July 2017 and July 2022.
Front Hum Neurosci
February 2025
Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
The Deep Brain Stimulation (DBS) Think Tank XII was held on August 21st to 23rd. This year we showcased groundbreaking advancements in neuromodulation technology, focusing heavily on the novel uses of existing technology as well as next-generation technology. Our keynote speaker shared the vision of using neuro artificial intelligence to predict depression using brain electrophysiology.
View Article and Find Full Text PDFOrphanet J Rare Dis
March 2025
Pediatric Endocrinology, Diabetology, Gynecology Department, Necker-Enfants Malades University Hospital, AP-HP Centre, 75015, Paris, France.
Background: The current development of gynecology services for children and adolescents seeks to meet needs both in the overall population and in patients with rare diseases. In France, the referral center for rare gynecological diseases specializes in four major types of conditions, namely, uterovaginal malformations, hereditary hemorrhagic diseases, rare benign breast diseases, and gynecological repercussions of rare chronic diseases.
Objective: To describe consecutive patients who had a first visit in 2018-2023 at the referral center for rare gynecological diseases at the Necker Pediatric University Hospital in Paris, France, and who were diagnosed with a condition in any of the four categories listed above.
Neurol Ther
March 2025
Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Introduction: Subjects with intellectual disability are usually excluded from clinical trials and there is limited evidence-based guidance for the choice of antiseizure medications in this vulnerable population. The study explored the effectiveness of brivaracetam (BRV) in people with epilepsy and intellectual disability.
Methods: BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) was a 12-month retrospective, multicenter study including adults prescribed adjunctive BRV.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!